Fenwal, Inc.

Pharmacia Corporation

Fenwel, Inc

Clay Little

Jean-Marc Payrat

Christian Stonig

Serge Hugard

Boudewijn Erasmus

Emmanuel Mignon

Christopher Daniel Gassman

Bryan Blickhan

Gopichand Yalamanchili

Michael Mao

Jerry D Clark

Jodi L Moe

Partha Mudipalli

Christine B Seymour

Thomas P Fraher

Patricia S Miyake

Kimberley C Allen

Tobin C Schilke

Jason A Hanko

Kimberly L Kolbert

Ahmad Y Sheikh

A blood or blood component collection and processing system, apparatus and method are disclosed. One embodiment includes a vascular access device and a blood collection container having a blood inlet and first and second blood component outlets. The outlets are located at opposite ends of the container, and a blood flow conduit extends between the vascular access device and collection container. The collection container is free of attachment to other blood collection containers when in an initial collection configuration at the time of collection.

Single collection bag blood collection system, method and apparatus

Crystalline forms of the p38 kinase inhibitor N-(2-hydroxyacetyl)-5-(4-piperidyl)-4-(4-pyrimidinyl)-3-(4-chlorophenyl)pyrazole are provided. These crystalline forms include (a) a first anhydrous crystalline form possessing improved physical stability relative to other solid-state forms of the compound; (b) a second anhydrous crystalline form possessing unique properties relative to other solid-state forms of the compound; (c) a third anhydrous crystalline form possessing unique properties relative to other solid-state forms of the compound; and (d) solvated crystalline forms, hydrated crystalline forms, and crystalline salt forms of the compound that are useful, for example, as intermediate solid-state forms in the preparation of other crystalline forms of the compound. Also provided are combinations and pharmaceutical compositions comprising at least one of these crystalline forms, processes for preparing these crystalline forms and for preparing compositions comprising these crystalline forms, and methods for the prophylaxis and/or treatment of a p38 kinase-mediated condition comprising administering to a subject a therapeutically effective amount of at least one of these crystalline forms.

Solid-state forms of N-(2-hydroxyacetyl)-5-(4-piperidyl)-4-(4-pyrimidinyl)-3-(4-chlorophenyl) pyrazole

Growing community of inventors

Lindenhurst, IL, United States of America

Clay Little